Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
NIH-NRSA (T32:HL 098069)
NIH-NRSA (T32:HL 098069)
NIH (R01 HL163640)
- License Information
-
More Information
Article History
Accepted: 7 June 2023
First Online: 14 June 2023
Compliance with Ethical Standards
:
: Albert J. Sinusas reports Institutional grants from Jubilant and Siemens; individual consulting fees unrelated to PET imaging compounds from MicroVide, LLC; patents related to SPECT imaging agent RP805 for MicroVide, LLC; member Cardiovascular Council of SNMMI (no funds received); receipt of equipment, materials, drugs, or other services from Lantheus (MTA LMI1195) and Jubilant (Rb-82 generator). The other authors declare that they have no conflict of interest.
: All reported studies and experiments involving human or animal subjects conducted by the authors mentioned in this article have been previously published and adhered to all relevant ethical standards, including the Helsinki Declaration and its amendments, institutional and national research committee norms, as well as international, national, and institutional guidelines.
